Insights

IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps

New insights from ATS 2026 reveal significant discrepancies between patient experiences and pulmonologist perceptions in IPF and PPF management.

Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026

ATS 2026 discussions on severe asthma treatment highlight the need to integrate patient-reported outcomes beyond lung function, addressing quality of life.

Immunological Insights Inform ILD & Transplant Outcomes

New immunological insights presented at ATS 2026 clarify mechanisms of interstitial lung disease progression and allograft rejection post-transplant.

EASL 2026 Forum: Enhancing Patient-Clinician Communication

The EASL 2026 Patient & Advocate Forum addresses critical gaps in patient-clinician communication and interprofessional collaboration.

EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging

EASL 2026 highlights the evolving role of non-invasive diagnostics in liver disease, offering improved accuracy for fibrosis and steatosis assessment.

HDV Management: EASL 2026 Highlights PegIFN-α as Standard

EASL 2026 discussions reaffirmed peginterferon alfa as the cornerstone of HDV management, with emerging therapies showing promise.

HRT and Cancer Risk: How the WHI Study Misled a Generation

The Women's Health Initiative's 2002 findings on HRT were widely misapplied. Reassessment of the data changes the risk calculus for most women.

Does Vaping Cause Cancer? What the 2025–26 Evidence Shows

Three new papers assess carcinogenicity, toxicant exposure, and oral microbiota changes in vapers. The evidence is concerning but incomplete.

GLP-1 Drugs and Oral Medication Absorption: What Prescribers Need to Know

GLP-1 receptor agonists slow gastric emptying, raising theoretical concerns about altered absorption of time-sensitive oral drugs. Evidence remains thin.

Hantavirus: Lethality, Transmission and What GPs Need to Know

Hantavirus carries case fatality rates up to 40% in some syndromes. Here is what clinicians and the public genuinely need to worry about.